ADAM12 and breast cancer: In an analysis of genomic changes in breast cancer, three somatic heterozygous mutations were found in ADAM12, p.D301H in the metalloprotease domain, p.G479E in the disintegrin domain, and p.L792F in the cytoplasmic domain (Fig. 1) [18].